PARP7 knockdown promotes tumor growth in MCF-7 human breast cancer cell xenografts lacking immune cells or a functional immune system, which could potentially explain these divergent outcomes (Rasmussen et al., 2023). The gene discussed is TIPARP; the disease is breast carcinoma.